Among 49 patients with MMR proficient (MMR-P) rectal cancer who underwent neoadjuvant chemotherapy, there was a significant increase of PD-1 positive T cells in the resected specimen compared to a control of 25 patients who had surgery alone (44). This evidence concerns the gene PDCD1 and rectal cancer.